William Febbo | executive |
Stephen Silvestro | executive |
Edward Stelmakh | executive |
Ryan Daniels | analyst |
Eric Martinuzzi | analyst |
David Grossman | analyst |
Constantine Davides | analyst |
Stephanie Davis | analyst |
William Wood | analyst |
Andrew D'Silva | analyst |
Good afternoon, everyone, and thank you for joining OptimizeRx's First Quarter Fiscal 2024 Earnings discussion. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by Chief Financial Officer, Ed Stelmakh; President, Steve Silvestro; General Counsel, Marion Odense Ford; and Senior Vice President of Corporate Finance, Andrew D'Silva. At the conclusion of today's earnings call, I will provide some important cautions regarding the forward-looking statements made by management during today's call.
I would like to remind everyone that today's call is being recorded and will be made available for replay via webcast only.